A trial is under way of the first new antibody medicine developed to treat covid-19 | MIT Technology Review

A trial is under way of the first new antibody medicine developed to treat covid-19 | MIT Technology Review: The news: Patients have started to receive the first antibody drug developed specifically to treat covid-19. It’s being tested in 32 patients at various doses in hospitals in the US. If it’s shown to be safe, the drug, referred to as LY-CoV555, will be studied in non-hospitalized coronavirus patients later this summer. The big idea:…